Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
3.850
+0.350 (10.00%)
At close: Dec 5, 2025, 4:00 PM EST
3.999
+0.149 (3.88%)
After-hours: Dec 5, 2025, 7:58 PM EST
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $139.53 million as of December 5, 2025. Its market cap has increased by 205.83% in one year.
Market Cap
139.53M
Enterprise Value
131.33M
1-Year Change
205.83%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has increased from $124.64M to $139.53M, an increase of 11.94%. That is a compound annual growth rate of 2.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 139.53M | 143.53% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |